IPTi in Mozambican Infants for Malaria Prevention

• Status: Unknown status
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate if intermittent preventive treatment in infants (IPTi) consisting of SP [Fansidar] given through the EPI scheme alongside routine immunisations at 3, 4 and 9 months of age reduces de incidence of clinical malaria up to 12 months of age

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Hospital Clinic of Barcelona
• Treatments: Fanasil, pyrimethamine drug combination; Pyrimethamine; Sulfadoxine

Criteria

Inclusion Criteria:

• Children from study area

• Signed informed consent

Exclusion Criteria:

• History of drug allergies